These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30685098)
1. Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors. Li J; Koerner J; Basler M; Brunner T; Kirk CJ; Groettrup M Kidney Int; 2019 Mar; 95(3):611-623. PubMed ID: 30685098 [TBL] [Abstract][Full Text] [Related]
2. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation. Li J; Basler M; Alvarez G; Brunner T; Kirk CJ; Groettrup M Kidney Int; 2018 Mar; 93(3):670-680. PubMed ID: 29229189 [TBL] [Abstract][Full Text] [Related]
3. A comparative analysis between proteasome and immunoproteasome inhibition in cellular and humoral alloimmunity. Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I Int Immunopharmacol; 2017 Sep; 50():48-54. PubMed ID: 28628770 [TBL] [Abstract][Full Text] [Related]
4. No prolongation of skin allograft survival by immunoproteasome inhibition in mice. Mundt S; Basler M; Sawitzki B; Groettrup M Mol Immunol; 2017 Aug; 88():32-37. PubMed ID: 28582644 [TBL] [Abstract][Full Text] [Related]
5. Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells. Woodle ES; Tremblay S; Brailey P; Girnita A; Alloway RR; Aronow B; Dasgupta N; Ebstein F; Kloetzel PM; Lee MJ; Kim KB; Singh H; Driscoll JJ Am J Transplant; 2020 Feb; 20(2):399-410. PubMed ID: 31595669 [TBL] [Abstract][Full Text] [Related]
6. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosis. Li J; Hu S; Johnson HWB; Kirk CJ; Xian P; Song Y; Li Y; Liu N; Groettrup M; Basler M Cardiovasc Res; 2023 May; 119(4):1030-1045. PubMed ID: 36464772 [TBL] [Abstract][Full Text] [Related]
7. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients. Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991 [TBL] [Abstract][Full Text] [Related]
8. Sustained reduction of alloantibody secreting plasma cells and donor specific antibody with proteasome inhibition in mice. Redfield RR; Lou Y; Rodriguez E; Rostami S; Parsons RF; Noorchashm H; Naji A; Abt PL Transpl Immunol; 2013 Dec; 29(1-4):11-6. PubMed ID: 24103731 [TBL] [Abstract][Full Text] [Related]
10. Bortezomib limits renal allograft interstitial fibrosis by inhibiting NF-κB/TNF-α/Akt/mTOR/P70S6K/Smurf2 pathway via IκBα protein stabilization. Suo C; Gui Z; Wang Z; Zhou J; Zheng M; Chen H; Fei S; Gu M; Tan R Clin Sci (Lond); 2021 Jan; 135(1):53-69. PubMed ID: 33289516 [TBL] [Abstract][Full Text] [Related]
11. Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with Lentiviruses. Vagapova E; Burov A; Spasskaya D; Lebedev T; Astakhova T; Spirin P; Prassolov V; Karpov V; Morozov A Cells; 2021 May; 10(5):. PubMed ID: 34066177 [TBL] [Abstract][Full Text] [Related]
12. An inhibitor of proteasome β2 sites sensitizes myeloma cells to immunoproteasome inhibitors. Downey-Kopyscinski S; Daily EW; Gautier M; Bhatt A; Florea BI; Mitsiades CS; Richardson PG; Driessen C; Overkleeft HS; Kisselev AF Blood Adv; 2018 Oct; 2(19):2443-2451. PubMed ID: 30266819 [TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitor treatment of antibody-mediated allograft rejection. Woodle ES; Alloway RR; Girnita A Curr Opin Organ Transplant; 2011 Aug; 16(4):434-8. PubMed ID: 21753709 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis. Basler M; Mundt S; Muchamuel T; Moll C; Jiang J; Groettrup M; Kirk CJ EMBO Mol Med; 2014 Feb; 6(2):226-38. PubMed ID: 24399752 [TBL] [Abstract][Full Text] [Related]
15. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model. Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767 [TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition for antibody-mediated rejection. Everly JJ; Walsh RC; Alloway RR; Woodle ES Curr Opin Organ Transplant; 2009 Dec; 14(6):662-6. PubMed ID: 19667989 [TBL] [Abstract][Full Text] [Related]
17. PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing T Liu H; Wan C; Ding Y; Han R; He Y; Xiao J; Hao J FASEB J; 2017 Apr; 31(4):1756-1766. PubMed ID: 28096232 [TBL] [Abstract][Full Text] [Related]
18. Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat. Vogelbacher R; Meister S; Gückel E; Starke C; Wittmann S; Stief A; Voll R; Daniel C; Hugo C Nephrol Dial Transplant; 2010 Nov; 25(11):3764-73. PubMed ID: 20466656 [TBL] [Abstract][Full Text] [Related]
19. Management of Plasma Cell-Rich Acute Rejection in Living-Related Kidney Transplant: Role of Proteasome Inhibitor. Abbas K; Mubarak M; Zafar MN; Musharraf W; Imam M; Aziz T; Rizvi AH Exp Clin Transplant; 2019 Feb; 17(1):42-46. PubMed ID: 29534661 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the Immunoproteasome Subunit LMP7 with ONX 0914 Ameliorates Graft-versus-Host Disease in an MHC-Matched Minor Histocompatibility Antigen-Disparate Murine Model. Zilberberg J; Matos J; Dziopa E; Dziopa L; Yang Z; Kirk CJ; Assefnia S; Korngold R Biol Blood Marrow Transplant; 2015 Sep; 21(9):1555-64. PubMed ID: 26093043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]